SNOA
Sonoma Pharmaceuticals, Inc.Company with tickers: SNOA
CIK
1367083
CUSIP
83558L303
Shares Outstanding
3,473,554
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $10,534,000 | USD | 2024-12-31 | 10-Q | 2026-02-10 |
| Revenue (ASC 606) | $10,534,000 | USD | 2024-12-31 | 10-Q | 2026-02-10 |
| Cost of Revenue | $6,597,000 | USD | 2024-12-31 | 10-Q | 2026-02-10 |
| Gross Profit | $3,937,000 | USD | 2024-12-31 | 10-Q | 2026-02-10 |
| Operating Expenses | $6,991,000 | USD | 2024-12-31 | 10-Q | 2026-02-10 |
| Research & Development | $1,403,000 | USD | 2024-12-31 | 10-Q | 2026-02-10 |
| Operating Income | $-3,054,000 | USD | 2024-12-31 | 10-Q | 2026-02-10 |
| Net Income | $-1,143,000 | USD | 2024-06-30 | 10-Q | 2026-02-10 |
| EPS (Basic) | $-2.40 | USD/shares | 2024-12-31 | 10-Q | 2026-02-10 |
| EPS (Diluted) | $-2.40 | USD/shares | 2024-12-31 | 10-Q | 2026-02-10 |